Longevity Acquisition Corporation Warrant
LOACW
LOACW was delisted on the 19th of March, 2021.
11 hedge funds and large institutions have $119K invested in Longevity Acquisition Corporation Warrant in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
56% less capital invested
Capital invested by funds: $271K → $119K (-$152K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$3.8K |
| 2 |
Walleye Trading
New York
|
+$990 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$80.2K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.01K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.38K |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$1.5K |
LOACW Hedge Fund Activity: Q3 2019 in Review
11 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Warrant (LOACW) for Q3 2019, worth a combined $119K — down 56% from $271K a quarter earlier.
Fund positioning in LOACW was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $3.8K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $80.2K sold.
- 11 institutional investors held Longevity Acquisition Corporation Warrant (LOACW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $119K of Longevity Acquisition Corporation Warrant stock for Q3 2019, down 56% quarter-over-quarter.
- 1 fund opened new Longevity Acquisition Corporation Warrant positions in Q3 2019 and 1 closed out, a net change of 0 holders.
- The largest Longevity Acquisition Corporation Warrant buyer in Q3 2019 was Goldman Sachs, an estimated $3.8K added.
- The largest Longevity Acquisition Corporation Warrant seller in Q3 2019 was K2 Principal Fund, an estimated $80.2K sold.
Based on aggregated 13F filings for Q3 2019.